tiprankstipranks
pc:sonir

Sonire Therapeutics

Sonire Therapeutics is a U.S.-based clinical-stage medical device company developing non-invasive high-intensity focused ultrasound (HIFU) sonic therapies for cancer, with a particular focus on pancreatic cancer. The company is advancing anesthesia-free, outpatient treatment options and progressing U.S. clinical programs and regulatory pathways following an FDA Breakthrough Device Designation.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$18M
Total Amount Raised$18M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$18M
Latest Funding Amount$18M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 15, 2026
Series A
$18.00M

Related News and Analysis